Related Experiment Video
Updated: Jun 2, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Epidemiology of Latent Tuberculosis in Moroccan Healthcare Workers: Prevalence Patterns and Predisposing Factors
Abdelhalim Boucaid1, Adil Zegmout1, Mohamed Bhairis2
1Pulmonology, Mohammed V Military Training Hospital, Rabat, MAR.
Background:
Among occupational hazards in healthcare settings, latent tuberculosis infection (LTBI) ranks as a major concern, particularly threatening healthcare workers (HCWs) in nations grappling with intermediate to high tuberculosis (TB) rates. Our study was conducted in Morocco, a country characterized by widespread Bacillus Calmette-Guérin (BCG) vaccination and a moderate TB burden of 93 cases per 100,000 inhabitants in 2022. We examined both the prevalence of LTBI among Moroccan HCWs and its various risk factors.
Methods:
A cross-sectional study was conducted from August 2022 to October 2024 in two Moroccan hospitals. One hundred forty-seven HCWs were recruited and screened for LTBI using the QuantiFERON-TB Gold In-Tube (QFT-GIT) test. Data on demographics, occupational characteristics, and potential risk factors were collected through standardized questionnaires. Statistical analysis included univariate and multivariate logistic regression to identify factors associated with LTBI.
Results:
The overall prevalence of LTBI was 32.65% (48/147). Multivariate analysis identified several independent risk factors: male gender (OR: 2.84; 95% CI: 1.54-5.22; p<0.001), age above 50 years (OR: 4.58; 95% CI: 1.50-13.90; p=0.007), smoking status (OR: 4.07; 95% CI: 1.63-10.14; p=0.003), and family history of TB (OR: 4.71; 95% CI: 1.33-16.65; p=0.016). Notably, neither specific work areas nor job categories were identified as significant risk factors in the final multivariate model.
Conclusions:
The observed LTBI prevalence among HCWs in Morocco demonstrates concordance with epidemiological data from comparable intermediate-burden nations. The elucidation of predisposing factors, with particular emphasis on non-occupational determinants, underscores the imperative for implementing systematic surveillance protocols and World Health Organization (WHO)-sanctioned infection prevention measures within healthcare facilities. These epidemiological findings provide an empirical foundation for the formulation and optimization of TB control strategies specifically tailored to the occupational health needs of Morocco's healthcare workforce.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

